Thiobutabarbital
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 5-sec-butyl-5-ethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 2095-57-0 |
| ATC code | None |
| PubChem | CID 3032373 |
| ChemSpider | 2297366 |
| UNII | 2N0251U7JH |
| Synonyms | Thiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid |
| Chemical data | |
| Formula | C10H16N2O2S |
| Mol. mass | 228.312 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia [1]
[edit] References
- ^ Rieg T, Richter K, Osswald H, Vallon V. Kidney function in mice: thiobutabarbital versus alpha-chloralose anesthesia. Naunyn Schmiedebergs Archives of Pharmacology. 2004 Oct;370(4):320-3.
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |